Greg Hedler has been in the field of pediatric oncology social work for 12 years and has had the fortunate to work at CHOP for the last 3 specializing in relapsed and refractory high risk Neuroblastoma patients.
- It's All GREEK To Me! The NEPENTHE Trial for Relapsed/Refractory Neuroblastoma; Personalized Molecularly Targeted treatment (200)
- Children's Hospital of Philadelphia
- Philadelphia, Pennsylvania